Multiple release of polyplexes of plasmids VEGF and bFGF from electrospun fibrous scaffolds towards regeneration of mature blood vessels
Source abstract
Abstract
Key challenges associated with the outcomes of vascular grafting (for example, to fully vascularize engineered tissues and promptly regenerate blood vessel substitutes) remain unsolved. The local availability of angiogenic growth factors is highly desirable for tissue regeneration, and plasmid loading in scaffolds represents a powerful alternative for local production of tissue-inductive factors. No attempt has been made so far to clarify the efficacy of electrospun fibers with the loading of multiple plasmids to promote tissue regeneration. In the present study, core-sheath electrospun fibers with the encapsulation of polyplexes of basic fibroblast growth factor-encoding plasmid (pbFGF) and vascular endothelial growth factor-encoding plasmid (pVEGF) were evaluated to promote the generation of mature blood vessels. In vitro release indicated a sustained release of pDNA for ∼4 weeks with as low as ∼10% initial burst release, and the release patterns from the single and twofold plasmid-loaded systems coincided. In vitro investigations on human umbilical vein endothelial cells showed that the sustained release of pDNA from fibrous mats promoted cell attachment and viability, cell transfection and protein expression, and extracellular secretion of collagen IV and laminin. The acceleration of angiogenesis was assessed in vivo after subcutaneous implantation of fibrous scaffolds, and the explants were evaluated after 1, 2 and 4 weeks' treatment by histological and immunohistochemical staining. Compared with pDNA polyplex infiltrated fibrous mats, the pDNA polyplex encapsulated fibers alleviated the inflammation reaction and enhanced the generation of microvessels. Although there was no significant difference in the total number of microvessels, the density of mature vessels was significantly enhanced by the combined treatment with both pbFGF and pVEGF compared with those incorporating individual pDNA. The integration of the core-sheath structure, DNA condensation and multiple delivery strategies provided a potential platform for scaffold fabrication to regenerate functional tissues.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Nerve injury and regeneration
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Tissue engineering: current challenges and expanding opportunities10.1126/science.1069210 ↗
2. Increased angiogenesis and blood vessel maturation in acellular collagen–heparin scaffolds containing both FGF2 and VEGF10.1016/j.biomaterials.2006.10.029 ↗
3. Update on therapeutic vascularization strategies10.2217/17460751.4.1.65 ↗
4. Angiogenic strategy for human ischemic heart disease: brief overview10.1023/B:MCBI.0000044383.01785.05 ↗
5. Growth factors in the treatment of diabetic foot ulcers10.1002/bjs.4019 ↗
6. Loading of collagen–heparin sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats10.1002/jbm.10267 ↗
7. Bilayered scaffold for engineering cellularized blood vessels10.1016/j.biomaterials.2010.02.002 ↗
8. Critical role of microenvironmental factors in angiogenesis10.1007/s11883-005-0011-7 ↗
9. Vascular endothelial growth factor and angiogenesis10.1124/pr.56.4.3 ↗
10. 3D systems delivering VEGF to promote angiogenesis for tissue engineering10.1016/j.jconrel.2010.11.028 ↗
11. Enhanced angiogenesis of porous collagen scaffolds by incorporation of TMC/DNA complexes encoding vascular endothelial growth factor10.1016/j.actbio.2009.04.004 ↗
12. Enhanced composite electrospun nanofiber scaffolds for use in drug delivery10.1517/17425247.5.10.1093 ↗
13. Controllable delivery of non-viral DNA from porous scaffolds10.1016/S0168-3659(02)00369-3 ↗
14. Eelcrospinning: applications in drug delivery and tissue engineering10.1016/j.biomaterials.2008.01.011 ↗
15. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and block copolymers10.1016/S0168-3659(03)00097-X ↗
16. Surface immobilization of poly(ethyleneimine) and plasmid DNA on electrospun poly(l-lactic acid) fibrous mats using a layer-by-layer approach for gene delivery10.1002/jbm.a.31870 ↗
17. Regulated non-viral gene delivery from coaxial electrospun fiber mesh scaffolds10.1016/j.jconrel.2009.12.009 ↗
18. Core–sheath structured fibers with pDNA polyplex loadings for optimal release profile and transfection efficiency as potential tissue engineering scaffolds10.1016/j.actbio.2011.02.031 ↗
19. Electrospun fibers with plasmid bFGF polyplexes loadings promote skin wound healing in diabetic rats10.1021/mp200246b ↗
20. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel10.1016/S0142-9612(03)00557-X ↗
21. Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants10.1016/j.biomaterials.2005.09.035 ↗
22. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization10.1016/j.biomaterials.2008.12.057 ↗
23. Optimization of preparative parameters for poly-dl-lactide–poly(ethylene glycol) microspheres with entrapped Vibrio cholera antigens10.1016/S0168-3659(98)00147-3 ↗
24. Electrospun fibrous mats with high porosity as potential scaffolds for skin tissue engineering10.1021/bm800476u ↗
25. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-210.1161/01.RES.0000019540.41697.60 ↗
26. Release pattern and structural integrity of lysozyme encapsulated in core–sheath structured poly(dl-lactide) ultrafine fibers prepared by emulsion electrospinning10.1016/j.ejpb.2007.10.016 ↗
27. Modified polyethylenimines as non-viral gene delivery systems for aerosol gene therapy: investigations of the complex structure and stability during air-jet and ultrasonic nebulization10.1016/j.jconrel.2004.09.005 ↗
28. Effect of wettability and surface functional groups on protein adsorption and cell adhesion using well-defined mixed self-assembled monolayers10.1016/j.biomaterials.2007.03.013 ↗
29. Surface engineering of electrospun polyethylene terephthalate (PET) nanofibers towards development of a new material for blood vessel engineering10.1016/j.biomaterials.2004.07.026 ↗
30. Biodegradable ultrafine fibers with core–sheath structures for protein delivery and its optimization10.1002/pat.1681 ↗
31. A novel hyaluronan-based biomaterial (Hyaff-11s) as a scaffold for endothelial cells in tissue engineered vascular grafts10.1016/j.biomaterials.2004.02.002 ↗
32. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumor: potential relationship to post-therapy tumor angiogenesis and recurrence10.1002/ijc.11059 ↗
33. Vascular-specific growth factors and blood vessel formation10.1038/35025215 ↗
34. Angiogenesis—a new target for future therapy10.1016/j.vph.2006.01.005 ↗
35. Vascular endothelial growth factor: molecular and biological aspects
36. In vivo imaging shows abnormal function of vascular endothelial growth factor-induced vasculature10.1089/hum.2006.162 ↗
37. The fibroblast growth factor family: structural and biological properties10.1016/0955-2235(89)90012-4 ↗
38. VEGF mediated inflammation precedes angiogenesis in adult brain10.1016/j.expneurol.2004.02.010 ↗
39. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells10.1016/j.actbio.2007.12.011 ↗
40. Evaluation of proinflammatory cytokine production induced by linear and branched polyethylenimine/plasmid DNA complexes in mice10.1124/jpet.105.100669 ↗
41. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice10.1016/S0168-3659(02)00349-8 ↗